These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 8945780

  • 1. Characterization of sodium hypochlorite degradation of beta-glucan in relation to its metabolism in vivo.
    Miura NN, Ohno N, Adachi Y, Yadomae T.
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2137-41. PubMed ID: 8945780
    [Abstract] [Full Text] [Related]

  • 2. Gradual solubilization of Candida cell wall beta-glucan by oxidative degradation in mice.
    Miura NN, Miura T, Ohno N, Adachi Y, Watanabe M, Tamura H, Tanaka S, Yadomae T.
    FEMS Immunol Med Microbiol; 1998 Jun; 21(2):123-9. PubMed ID: 9685001
    [Abstract] [Full Text] [Related]

  • 3. Preparation and properties of metabolically 3H- or 13C-labeled (1-->3)-beta-D-glucan, SSG, from Sclerotinia sclerotiorum IFO 9395.
    Suda M, Ohno N, Adachi Y, Yadomae T.
    Carbohydr Res; 1994 Feb 17; 254():213-9. PubMed ID: 8180985
    [Abstract] [Full Text] [Related]

  • 4. Kupffer cells play important roles in the metabolic degradation of a soluble anti-tumor (1-->3)-beta-D-glucan, SSG, in mice.
    Suda M, Ohno N, Hashimoto T, Koizumi K, Adachi Y, Yadomae T.
    FEMS Immunol Med Microbiol; 1996 Sep 17; 15(2-3):93-100. PubMed ID: 8880133
    [Abstract] [Full Text] [Related]

  • 5. Metabolic 13C-labeling of an antitumor (1-->3)-beta-D-glucan, SSG, from Sclerotinia sclerotiorum IFO 9395.
    Suda M, Ohno N, Adachi Y, Yadomae T.
    Biosci Biotechnol Biochem; 1995 Feb 17; 59(2):203-7. PubMed ID: 7766018
    [Abstract] [Full Text] [Related]

  • 6. Solubilization of yeast cell-wall beta-(1-->3)-D-glucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction.
    Ohno N, Uchiyama M, Tsuzuki A, Tokunaka K, Miura NN, Adachi Y, Aizawa MW, Tamura H, Tanaka S, Yadomae T.
    Carbohydr Res; 1999 Mar 31; 316(1-4):161-72. PubMed ID: 10420595
    [Abstract] [Full Text] [Related]

  • 7. Antitumor activity of a highly branched (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395.
    Ohno N, Kurachi K, Yadomae T.
    J Pharmacobiodyn; 1987 Sep 31; 10(9):478-86. PubMed ID: 3437391
    [Abstract] [Full Text] [Related]

  • 8. Preparation and antitumor activity of hydroxyethylated derivatives of 6-branched (1----3)-beta-D-glucan, SSG, obtained from the culture filtrate of Sclerotinia sclerotiorum IFO 9395.
    Kurachi K, Ohno N, Yadomae T.
    Chem Pharm Bull (Tokyo); 1990 Sep 31; 38(9):2527-31. PubMed ID: 2285987
    [Abstract] [Full Text] [Related]

  • 9. Reactivity of Limulus amoebocyte lysate towards (1----3)-beta-D-glucans.
    Ohno N, Emori Y, Yadomae T, Saito K, Masuda A, Oikawa S.
    Carbohydr Res; 1990 Oct 25; 207(2):311-8. PubMed ID: 2076521
    [Abstract] [Full Text] [Related]

  • 10. Antitumor activity and structural characterization of a (1----3)-beta-D-glucan extracted with cold alkali from sclerotia of Sclerotinia sclerotiorum IFO 9395.
    Shinohara H, Ohno N, Yadomae T.
    Chem Pharm Bull (Tokyo); 1988 Feb 25; 36(2):819-23. PubMed ID: 3409388
    [No Abstract] [Full Text] [Related]

  • 11. Inhibitory effect of beta-glucans on zymosan-mediated hydrogen peroxide production by murine peritoneal macrophages in vitro.
    Adachi Y, Ohno N, Yadomae T.
    Biol Pharm Bull; 1993 May 25; 16(5):462-7. PubMed ID: 8364492
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A beta-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway.
    Czop JK, Austen KF.
    J Immunol; 1985 Apr 25; 134(4):2588-93. PubMed ID: 2579146
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of soluble fungal (1-->3)-beta-D-glucan obtained from Sclerotinia sclerotiorum on alveolar macrophage activation.
    Sakurai T, Ohno N, Suzuki I, Yadomae T.
    Immunopharmacology; 1995 Aug 25; 30(2):157-66. PubMed ID: 8530257
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Different role of serum components and cytokines on alveolar macrophage activation by soluble fungal (1-->3)-beta-D-glucan.
    Sakurai T, Kaise T, Yadomae T, Matsubara C.
    Eur J Pharmacol; 1997 Sep 10; 334(2-3):255-63. PubMed ID: 9369356
    [Abstract] [Full Text] [Related]

  • 18. Relationship between the physical properties of Candida albicans cell well beta-glucan and activation of leukocytes in vitro.
    Ishibashi K, Miura NN, Adachi Y, Ogura N, Tamura H, Tanaka S, Ohno N.
    Int Immunopharmacol; 2002 Jul 10; 2(8):1109-22. PubMed ID: 12349948
    [Abstract] [Full Text] [Related]

  • 19. Tissue distribution of intraperitoneally administered (1-->3)-beta-D-glucan (SSG), a highly branched antitumor glucan, in mice.
    Suda M, Ohno N, Adachi Y, Yadomae T.
    J Pharmacobiodyn; 1992 Aug 10; 15(8):417-26. PubMed ID: 1479542
    [Abstract] [Full Text] [Related]

  • 20. The oxidative degradation of barley β-glucan in the presence of ascorbic acid or hydrogen peroxide.
    Mäkelä N, Sontag-Strohm T, Maina NH.
    Carbohydr Polym; 2015 Jun 05; 123():390-5. PubMed ID: 25843872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.